CD147-CART

BIOLOGICAL2 trials

Sponsors

Xijing Hospital

Conditions

Advanced Hepatocellular CarcinomaCD147 PositiveRecurrent Glioblastoma

Early Phase 1

CD147-CART Cells in Patients With Recurrent Malignant Glioma.

Xijing HospitalCD147 Positive, Recurrent Glioblastoma

Start: 2019-05-30End: 2022-05-30Target: 31Updated: 2020-05-07

Phase 1

A Study of CD147-targeted CAR-T by Hepatic Artery Infusions for Very Advanced Hepatocellular Carcinoma

Xijing HospitalAdvanced Hepatocellular Carcinoma

Start: 2019-05-27End: 2022-05-27Target: 34Updated: 2019-08-28